Lineage Cell Therapeutics (LCTX) Interest & Investment Income (2013 - 2021)
Lineage Cell Therapeutics' (LCTX) quarterly Interest & Investment Income came in at $2000.0 in Q1 2021, down 99.51% year-on-year from $405000.0 in Q1 2020, and little changed quarter-over-quarter from $2000.0 in Q4 2020.
Lineage Cell Therapeutics (LCTX) Interest & Investment Income (2013 - 2021) Analysis & Trends
Lineage Cell Therapeutics' Interest & Investment Income history runs 5 years deep, the most recent figure standing at $2000.0 for Q1 2021.
- On a quarterly basis, Interest & Investment Income fell 99.51% year-over-year to $2000.0 in Q1 2021; TTM through Mar 2021 was $636000.0, a 61.41% decrease from a year earlier, with the FY2020 full-year figure at $1.0 million, down 38.34% from the prior year.
- Interest & Investment Income held at $2000.0 in Q1 2021 per LCTX's latest filing, from $2000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $442000.0 in Q1 2019 and bottomed at $2000.0 in Q4 2020.
- The 3-year median for Interest & Investment Income is $399000.0 (2019), against an average of $302888.9.
- Biggest YoY gain for Interest & Investment Income was 8.37% in 2020; the steepest drop was 99.51% in 2020.
- Year by year, Interest & Investment Income stood at $407000.0 in 2019, then plunged by 99.51% to $2000.0 in 2020, then changed by 0.0% to $2000.0 in 2021.
- Per Business Quant, the three latest LCTX Interest & Investment Income figures stand at $2000.0 (Q1 2021), $2000.0 (Q4 2020), and $252000.0 (Q3 2020).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Lineage Cell Therapeutics | 251.15 Mn | 188.44 Mn | 1.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 2,000.00 |
| Dec 31, 2020 | 2,000.00 |
| Sep 30, 2020 | 252,000.00 |
| Jun 30, 2020 | 380,000.00 |
| Mar 31, 2020 | 405,000.00 |
| Dec 31, 2019 | 407,000.00 |
| Sep 30, 2019 | 399,000.00 |
| Jun 30, 2019 | 437,000.00 |
| Mar 31, 2019 | 442,000.00 |
| Sep 30, 2014 | -1,210.00 |
| Jun 30, 2014 | 1,120.00 |
| Mar 31, 2014 | -2,650.00 |
| Dec 31, 2013 | 3,000.00 |